Related Experiment Videos
Pathogenesis of glucose intolerance in uremia
Metabolism: Clinical and Experimental
|December 1, 1978
Summary
Glucose intolerance in uremia stems from peripheral tissue insulin resistance, not hepatic issues. Dialysis improves insulin sensitivity, but it remains impaired in uremic patients.
Area of Science:
- Nephrology
- Endocrinology
- Metabolic Disorders
Background:
- Uremia is associated with glucose intolerance.
- The underlying mechanisms of glucose intolerance in uremia require further investigation.
Purpose of the Study:
- To investigate the pathogenesis of glucose intolerance in uremia.
- To assess insulin sensitivity and glucose metabolism in uremic patients before and after dialysis.
Main Methods:
- Employed the glucose clamp technique, including hyperglycemic and euglycemic insulin clamps.
- Measured glucose infusion rate (M), insulin response (I), and M/I ratio to assess insulin sensitivity.
- Evaluated basal hepatic glucose production and insulin binding to monocytes.
Main Results:
- Uremic patients exhibit significant peripheral tissue insensitivity to insulin.
- Dialysis improves insulin sensitivity (M/I ratio) but does not fully normalize it.
- Basal hepatic glucose production is unaffected by uremia.
- No correlation was found between insulin binding to monocytes and tissue insulin sensitivity.
Conclusions:
- Glucose intolerance in uremia is primarily due to peripheral insulin resistance.
- Insulin secretion is often enhanced to compensate for insulin resistance.
- Hepatic glucose production remains normal in uremia.
- The cellular defect causing insulin resistance likely lies in intracellular metabolism or glucose transport.